| |
At Biopsy |
6 months after PSL |
| n |
55 |
51 |
| SBP(mmHg) |
116 ± 21 |
114 ± 19 |
| DBP(mmHg) |
68 ± 19 |
63 ± 18 |
| eGFR(ml/min/1.73 m2) |
124 ± 42.1 |
129 ± 36.3 |
| Proteinuria(g/g Cr) |
1.41 ± 1.21 |
0.22 ± 0.44 * |
| Macrohematuria |
17/55(30.9%) |
0/51(0%) |
| Microhematuria RBC ≥ 50/hpf |
21/55(38.2%) |
2/51(3.9%) |
| 20 ≤ RBC < 50/hpf |
11/55(20%) |
9/51(17.6%) |
| RBC < 20/hpf |
6/55(12%) |
40/51(78.4%) |
| Urinary podocyte(/ml) |
3.76 ± 1.82 |
0.85 ± 0.91 * |
| Nephrotic syndrome |
5/55(9.1%) |
0/51(0%) |
| Renal insufficiency |
1/55(2%) |
0/51(0%) |
PSL: prednisolone; SBP: systolic blood pressure; DBP: diastolic blood pressure;
hpf: high-power field; eGFR: estimated glomerular filtration rate; RBC: red blood
cells.
*p<0.05 |
